Aurora Cannabis to Speak at the Global Cannabis Regulatory Summit
NASDAQ | TSX: ACB
Canada's Largest Medical Cannabis Company to Participate as an Industry Leader in the Inaugural Regulatory Event
Aurora Cannabis Inc. (NASDAQ: ACB)(TSX: ACB), a key player in the global medical cannabis sector, is excited to announce its participation in the 2025 Global Cannabis Regulatory Summit (GCRS). This event, hosted by Artemis Growth Partners, will take place within the U.S. Capitol Complex, providing a significant platform for industry discussions.
Rick Savone, Senior Vice President of Global Government Relations at Aurora, expressed enthusiasm about the opportunity to speak at this prestigious summit. He stated, "The opportunity to speak on this global stage underscores our position as industry leaders and demonstrates our ability to advocate for policy reform around the world. It is essential that we work together—across borders and sectors—to seize the opportunities that lie ahead for our industry. We are eager to engage with leaders from around the world as we continue to advance policies that drive resilient growth and positive change."
The GCRS will gather regulators, Congress members, international policy experts, and executives from the cannabis industry, each aiming to discuss and shape the future of the cannabis market worldwide. Aurora's participation is set to promote significant dialogue on various topics related to cannabis regulation.
Understanding Cannabis Usage Across Different Jurisdictions
During the summit, Aurora will delve into panel discussions that highlight the distinctions between medical cannabis and adult-use cannabis. The dialogue aims to provide insights into how jurisdictions with established medical cannabis programs can influence regulatory frameworks in emerging markets. This exchange of ideas is crucial as more regions consider the legalization and regulation of cannabis.
About Aurora Cannabis
Aurora is dedicated to enhancing lives through cannabis, serving both medical and consumer markets across regions such as Canada, Europe, Australia, and New Zealand. With its headquarters located in Edmonton, Alberta, Aurora is a pioneer within the global cannabis sector. The company is committed to high-quality cannabis products and innovation, continuously working to introduce new brands and varieties to its portfolio.
Aurora's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being, and Greybeard. The medical cannabis brands, leading in their respective fields, include MedReleaf, CanniMed, Aurora, and Whistler Medical Marijuana Co. Furthermore, Aurora has established brands in international markets such as Pedanios, IndiMed, and CraftPlant. The company holds a controlling interest in Bevo Farms Ltd., known as North America's leading provider of propagated agricultural plants.
Company's Commitment to Industry Leadership
Driven by a passion for science and a commitment to quality, Aurora's brands are recognized as leaders across medical, wellness, and adult recreational markets. This dedication places Aurora at the forefront of the cannabis industry, as they strive to maintain high standards in production and distribution. Aurora's stake in the regulatory summit continues to highlight their role as an advocate for sensible cannabis policy reform.
Follow Aurora Cannabis
Aurora invites individuals interested in their journey and contributions to the cannabis sector to engage with them on various social media platforms. The company is active on platforms including X and LinkedIn, where they share updates, insights, and news related to the cannabis industry, further enriching the dialogue surrounding cannabis regulation and its impact.
Frequently Asked Questions
What is the GCRS?
The Global Cannabis Regulatory Summit (GCRS) is an event that brings together industry leaders, regulators, and policymakers to discuss cannabis regulation and policy reform.
Who is representing Aurora Cannabis at the summit?
Rick Savone, the Senior Vice President of Global Government Relations, will represent Aurora, emphasizing the company's leadership and advocacy efforts.
What topics will be discussed at the summit?
Key topics will include the differences between medical and adult-use cannabis, regulatory experiences, and the sharing of insights from established markets.
Where is Aurora Cannabis headquartered?
Aurora Cannabis is headquartered in Edmonton, Alberta, Canada, serving both local and international markets.
What is Aurora's commitment to product quality?
Aurora is dedicated to high-quality cannabis production, focusing on innovation and consumer satisfaction across all their product offerings.
